Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
31 hedge funds and large institutions have $68.7M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.
333% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 3
89% more capital invested
Capital invested by funds: $36.4M → $68.7M (+$32.3M)
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
48% more funds holding
Funds holding: 21 → 31 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$7.16M |
| 2 |
DA
DSC Advisors
Chicago,
Illinois
|
+$5.4M |
| 3 |
Jennison Associates
New York
|
+$4.3M |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$3.64M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$5.14M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.32M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$626K |
| 4 |
DM
Deerfield Management
New York
|
-$583K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$241K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $29K | +$28.1K | +3,140 | New |
|
|
GWM
27
Gupta Wealth Management
San Diego,
California
| $28K | +$26.8K | +3,000 | New |
|
28
UBS Group
Zurich,
Switzerland
| $26K | +$25.6K | +2,857 | New |
|
|
SFPIA
29
Stevens First Principles Investment Advisors
Newport Beach,
California
| $19K | – | – | – |
|
|
BIM
30
BlackRock Investment Management
Wilmington,
Delaware
| $10K | – | – | – |
|
|
LTFS
31
Ladenburg Thalmann Financial Services
Miami,
Florida
| $5K | – | – | – |
|
|
32
JP Morgan Chase
New York
| – | -$5.14M | -732,890 | Closed |
|
|
33
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$241K | -34,499 | Closed |
|
FOMX Hedge Fund Activity: Q1 2015 in Review
31 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q1 2015, worth a combined $68.7M — up 89% from $36.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new FOMX positions and 3 closed out — a net gain of 10 holders — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $7.16M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $5.14M sold.
- 31 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q1 2015, up from 21 in Q4 2014.
- Funds reported $68.7M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q1 2015, up 89% quarter-over-quarter.
- 13 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q1 2015 and 3 closed out, a net change of +10 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q1 2015 was Baker Bros. Advisors, an estimated $7.16M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q1 2015 was JP Morgan Chase, an estimated $5.14M sold.
Based on aggregated 13F filings for Q1 2015.